N-Glycans profiling of MAbs EG2-hFc and Rituximab using the AdvanceBio Gly-X N-Glycan Prep with InstantPC kit

Download this application note to find a method for N-Glycan profiling. Protein glycosylation is one of the main sources of heterogeneity of therapeutic glycoproteins, with a potential impact on safety and efficacy, and is therefore considered a critical quality attribute (CQA). Therefore, this type of workflow holds great potential for reliable and reproducible sample preparation for high-throughput glycan profiling and quantitation. It can also easily be adapted to any analytical laboratory requirements.